Track record · closed signal

Insulet Corporation (PODD) — closed signal from June 4, 2026

Partial Published before the outcome was known, scored automatically when the window closed on September 2, 2026 — -1.2% at the close.

Predicted vs. what happened

PODD price · publication thesis → realized outcomesplit-adjusted
$149.99 Published $187.48 Target $148.14 Window close $172.92 Peak
$145.00 – $153.00Entry zone — fair-value band
$149.99Published — price the day we called it
$187.48Target — the price the thesis aimed for
$172.92Peak — highest point inside the window, not a realized return
$148.14Window close — end-of-window price, context only

What happened

Partial

Reached 61% of the predicted growth at its peak, without hitting the target.

At window close
-1.2%
realized, from the publication price to the last close inside the window
Peak gain
+15.3%
peak, from the publication price — not a realized return
S&P 500, same window
+1.3%
SPY over the identical days, dividend-adjusted
Window close
$148.14
last close inside the window, ended September 2, 2026
Peak price
$172.92
peak on July 28, 2026 — not a realized return
Days to target
—

The thesis — published June 4, 2026

Predicted growth
+25%
over the measurement window
Target price
$187.48
the price the thesis aimed for
Entry zone
$145.00 – $153.00
the fair-value band we waited for
Price at publication
$149.99
published June 4, 2026
Confidence
81%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Insulet's main product, Omnipod, is selling steadily and the company keeps hitting its earnings targets. Upcoming ADA presentations and a software update give concrete short-term news that could help the stock. Price sits under its recent trend but buying activity is picking up, so the situation looks like an early recovery without needing to chase higher levels. Low trading volume tempers conviction.

Primary drivers

  • Steady demand for Omnipod as more people use diabetes devices
  • ADA presentations provide near-term clinical news
  • Wider sensor compatibility expands the product's usefulness
  • Earnings consistently beating expectations supports confidence

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All PODD signals